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Introduction 
There are substantial global investments being made in health information technology (HIT) as 
governments and providers strive to improve the safety, quality and efficiency of healthcare.(1) 
Accompanying this trend is a growing HIT industry projected to be worth around $230 billion by 2020, with 
a range of new applications becoming available daily.(2) These vary significantly in complexity, ranging 
from foundational technologies that impact on a range of care providers  (e.g. electronic health records 
(EHRs)) to relatively discrete functionality affecting a limited range of settings and users (e.g. specialist apps 
for patients with chronic conditions) (see Box 1). 
 
Randomized controlled trials (RCTs) of complex HIT interventions are important and appropriate to 
evaluate effectiveness in many contexts, particularly if they are complemented by process and in-depth 
qualitative evaluations which yield insights into why the intervention was effective/ineffective and its likely 
generalizability.(3) But HIT represents some challenges for this traditional biomedical evaluation approach. 
It may have relatively small diffuse effects that are often difficult to trace and attribute as it involves re-
designing existing organizational processes and ways of working (e.g. when implementing EHRs).(4) The 
effect of the intervention can also be heavily shaped by the context and the way it is implemented;(5) this 
may include, for example, varying organizational strategies, shifting responsibilities of healthcare 
professionals (e.g. towards a greater emphasis on data entry), increased managerial control (e.g. through 
review of data held within systems), changing power structures and whether or not computerized decision 
support (CDS) is switched on. HIT is also often rapidly evolving and a certain user interface, for example, 
may no longer exist by the time an RCT evaluative cycle (which typically takes years) has been 
completed.(6)   
 
New design and evaluation approaches are thus needed alongside RCTs to provide a broader array of 
evaluative approaches to investigating the effectiveness of different forms of HIT. Building on our previous 
work highlighting the importance of continuous systemic HIT evaluation,(7) we consider how evaluation 
approaches based on human factors engineering (HFE) may help to address some of these needs. 
 
In which contexts are RCTs appropriate? 
RCTs are of considerable importance to evaluating the effectiveness of interventions – including HIT – 
because they have the potential to minimize the risk of bias, allocate confounders randomly between 
intervention arms, and produce generalizable results.(8) This design is appropriate and indeed essential for 
some HIT contexts where clear effects on a limited number of outcomes can be anticipated. For instance, 
if aiming to investigate the effectiveness of a safety/business-critical medical prototype device with 
discrete effects on health outcomes or if interventions are particularly expensive, then RCT designs are 
likely to be an appropriate summative evaluative tool. Indeed, RCTs and, alternatively quasi-RCTs, have 
been very useful in relation to evaluating HIT, particularly when combined with embedded process and 
qualitative evaluations.(5) 
 
Why are RCTs problematic for some types of technology/context? 
Our experiences have however indicated that there are a number of contexts where RCTs and quasi-RCTs 
are not feasible and/or appropriate. Firstly, some HIT, such as EHRs, is foundational and therefore has 
multiple small effects that are often hard to measure. Furthermore, with these types of technology, it can 
be difficult to establish appropriate controls, as HIT implementations often involve large organizational 
transformations across care settings that are not directly comparable. Secondly, implementation context 
matters and should not be treated as a confounder. This may include the hospital environment into which 
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systems are implemented, the leadership style and implementation strategy pursued, and user attributes 
such as personality and competencies. Thirdly, many technologies rapidly evolve (e.g. by being refined, 
upgraded, customized) or they cease to exist altogether (e.g. apps), which means that the intervention may 
vary over time. As a result, many complex HIT systems that are used across a range of contexts lack usability 
and fail to achieve their true potential as they are often used in ways other than those intended.(9) 
 
To address some of these challenges, a HFE approach may provide an alternative more agile approach to 
evaluating HIT, as this takes into account the changing nature of technology whilst paying close attention 
to the context of system use and the variety of settings in which technologies may be implemented.  
 
What is HFE and when is it appropriate? 
User-centered approaches to evaluation tend to be practically oriented, focusing on the iterative 
evaluation of the technology at hand; they are typically less concerned with producing generalizable 
results.(10) Although some traditional experimental evaluation approaches exist in these settings (e.g. 
performance and effectiveness analysis), there is an explicit focus on evaluating technology throughout the 
lifecycle, often involving iterative development and evaluation.(11) An example of such an iterative 
approach to system development is rapid application development (RAD). This employs iterative methods 
that allow technological prototypes to be developed quickly and then tested and refined in real-world 
settings, often based on user feedback. It is well-suited for complex environments where effects of 
technologies and user requirements are hard to predict in advance (e.g. when technologies require a high 
degree of interactivity). This may draw on cognitive task analysis (CTA), where user needs and workflows 
are assessed before new technology is introduced, followed by detailed analysis surrounding how new 
systems affect existing practices.(12) Although somewhat overlapping (e.g. action research can be used as 
a methodology in HFE), HFA differs from action research in that it has a more explicit focus on technological 
design whereas action research is a research methodology.  
 
HFE is thus a usability engineering-based approach to “designing systems for human use”, helping to 
develop systems over time to bring maximum benefits to users.(12) This includes prospective evaluation 
approaches that allow systems to be refined in ways that promote their effective use over time. The 
underlying assumption is that HIT only works if it is usable and fits with users’ practices, and HFE helps to 
design usable and useful systems.(13) Methods focus on obtaining a clear understanding of what task 
needs to be undertaken (the aim) and helping to design systems that assist and motivate users to 
accomplish these tasks (the tool). From this perspective, evaluation of technology should therefore focus 
on exploring its suitability for accomplishing a task from the perspective of users, the degree to which 
technologies support and enhance human effectiveness, and the degree to which they fit within their 
context of use.  
 
Although attention to HFE in design and development of systems is important, there is also growing 
recognition that ongoing design iterations are an inherent feature of the technology lifecycle.(14) These 
iterations may involve co-evolution of systems and users, where technologies and ways of using them are 
changed over time to suit contexts of use. These iterations are often difficult to anticipate ahead of time 
and can create opportunities for system improvement as well as expose design limitations that may be 
important to address to improve workflows and mitigate potential safety risks.(15) Steps involved in this 
prospective evaluation process include understanding current practices and needs, identifying possible 
design solutions, checking proposed solutions against needs, testing of implemented systems with users, 
and continuous co-evolution between design and use (see Table 1).(16) Techniques and tools used in HFE 
are outlined in Table 2; see also texts such as (17,18). 
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Towards re-conceptualizing HIT evaluation approaches 
Both RCT-based and HFE-based approaches to evaluation are essential for evaluating the effectiveness of 
HIT, but it is important to recognize that the appropriateness of methods depends on the needs emerging 
from different contexts/technologies. The choice of methods should be determined by the type of HIT to 
be evaluated, its stage of development, and the key evaluation questions in that situation. For example, 
HFE approaches work well for technologies that have distributed effects and can be tested and refined in 
collaboration with users in real-world settings. In comparison, RCTs are necessary for pre-market testing 
of safety-critical medical devices and for determining the impact of technologies on health outcomes.(19) 
We propose a decision tree to guide evaluators in relation to choice of methods in Figure 1. 
 
A key future activity should also include establishing consensus amongst evaluators on which approaches 
are best suited to different types of technologies and evaluation questions, and establishing key influence 
diagrams to consider appropriate surrogate markers.(20) For instance, safety/business-critical 
technologies (e.g. infusion devices, hemodialysis machines, clinical decision support systems) are likely to 
require extensive up-front development (ideally in close collaboration with users) and extensive 
effectiveness testing, whilst prototypes of less critical devices (e.g. activity trackers) may be tested and 
refined in close collaboration with users in real-world settings without significant safety implications.  
 
Conclusions 
Traditional RCT-based evaluation paradigms, although suitable for determining effectiveness surrounding 
health outcomes, are not appropriate for evaluating the effectiveness of different types of HIT at different 
stages of development. HFE-based evaluation approaches can help to address these shortcomings, 
particularly in relation to designing systems that fulfill user needs and involve users throughout the 
development process.  
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Figures and tables 
 
Box 1: Examples of existing HITs and evaluation questions 
 
EHRs (also called electronic medical records (EMRs), electronic patient records (EPRs), depending on the 
focus): Issues including usability by non-clinical staff, changing relationships between clinician and patient, 
and new models of care. 
 
Clinical decision support systems, computerized physician order entry, Electronic Medication 
Administration Records, patient barcode scanning, and related technologies for patient identification and 
medication management: Safety, interoperability and usability are all important for such technologies. 
 
Technologies for medication administration and other therapies, including infusion pumps and syringe 
drivers (sometimes with dose error reduction software) for medication administration, and hemodialysis 
technology: Safety and usability are paramount across all settings, but particularly challenging for home 
use. 
 
Monitoring technologies: Ease of use and of interpretation of the information displayed are important. 
 
In vitro diagnostics: As well as ease of use (particularly for delivering reliable results), it may be important 
to consider the care pathway to ensure people receive appropriate support depending on the diagnostic 
results. 
 
Digital behavior change interventions: Effective engagement is essential if the intervention is to be 
effective. Individual differences (knowledge, motivations, self-efficacy, etc.) influence engagement. 
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Table 1: Lifecycle perspective of implementing HIT and HFE-informed lines of inquiry 
 
Lifecycle stage HFE questions 
Conceptualization What are the organization’s or individual’s needs? 
Project initiation What kinds of solutions (not necessarily technological) are there to address those 
needs? 
Functional specification 
 
If the solution is technological, then what functionalities are likely to address the 
specified needs?  
Who will the users of the technology be? 
Drafting a business 
case 
 
[For each group of users]: how will this fit in their workflow? How will their 
workflow need to be adapted to exploit the new technology? What are the costs 
and benefits to them (in their role) in using the new system, and how can we 
make the benefits outweigh the costs? 
Procurement/tendering What technologies exist and which ones are likely to address the 
organizational/user needs? Does a new technology need to be designed and 
implemented? 
System choice How does the new technology support the long-term agenda of the organization 
(e.g. for patient engagement / shared care, interoperating with other new 
systems)?  
How easy is the new system to use? How safe is it (e.g. limiting effects of human 
error)? (Particularly important if it’s only used occasionally by that particular user 
group) 
Contracting 
 
How can organizations and suppliers work together to implement a technology 
that is usable and brings benefits to users? 
Pre-implementation How exactly do workflows need to be changed across different professions and 
settings? 
Implementation How have planned changes to workflows played out in reality? Are there adverse 
consequences for some groups of users? 
System optimization How can users and organizations help to shape systems to better fit with their 
contexts of use? What are the opportunities for improvement and what are 
design limitations?  
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Table 2: Methodologies commonly used in human factors engineering 
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Tool Features Useful for Considerations 
Observation 
(sometimes 
called 
‘ethnography’) 
Observing people 
working and using HIT 
Understanding 
what people do in 
practice and what 
they need 
Usefully complemented by interviews 
or Contextual Inquiry, to better 
understand what is observed 
Interviews 
(usually semi-
structured) 
Interviewing people 
about their work, their 
experiences of HIT, their 
requirements for future 
HIT, etc. 
Understanding 
people’s 
perceptions and 
experiences 
People have difficulty reporting 
accurately on what they do 
Contextual 
Inquiry 
Combining observations 
and interviews to 
understand work and 
the use of HIT 
Gaining insights 
for design based 
on a better 
understanding of 
people’s work and 
activities 
Takes place within the context where 
people use HIT  
Diary studies Participants maintain a 
diary of relevant 
thoughts and 
experiences when using 
the HIT 
Gathering 
information about 
situated use (e.g. 
of mobile HIT) 
Quality of data is dependent on 
commitment of participants. 
Task analysis Systematically 
decomposing tasks (that 
the HIT supports) into 
sub-tasks to analyse the 
sequence and 
performance criteria  
Supports 
systematic 
thinking about 
user tasks and 
how they are 
achieved with the 
HIT 
Should be based on empirical data of 
real user tasks 
Cognitive Task 
Analysis 
Systematic analysis of 
the cognitive tasks 
(user’s thought 
processes) when using 
the HIT 
Analysis of issues 
such as likely 
errors, mental 
workload and 
compatibility 
between tasks as 
defined by HIT 
and the way 
people think 
about their tasks 
Requires expertise in cognitive 
science 
Rapid application 
development 
(RAD) 
Employs iterative 
methods that allow 
technological prototypes 
to be developed quickly 
and then tested and 
refined in real-world 
settings, often based on 
user feedback 
Well-suited for 
complex 
environments 
where effects of 
technologies and 
user 
requirements are 
hard to predict in 
advance (e.g. 
when 
technologies 
require a high 
degree of 
interactivity) 
Close collaboration between users, 
implementers and developers is 
essential 
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Heuristic 
evaluation 
A checklist approach to 
checking the device 
interface for usability 
and safety based on 
‘rules of thumb’ 
Checking for 
obvious problems 
at early stages of 
development 
Needs expertise in understanding and 
interpreting the heuristics. 
Dependent on the expertise (and 
biases) of the evaluators 
Cognitive 
Walkthrough 
An expert review 
approach that involves 
‘walking through’ the 
steps of an interaction 
between user and 
device, reasoning about 
possible user errors. One 
common form of 
cognitive task analysis. 
Early review, 
focusing on user 
cognition, 
requiring access 
to a prototype HIT 
Should be conducted by experts in 
cognitive science. Assumes that the 
HIT is ‘walk up and use’. 
User testing 
(often with think-
aloud) 
Testing the HIT with 
representative users in a 
simulated use 
environment. Users are 
often invited to 
articulate thoughts while 
interacting with HIT 
Identifying which 
HIT features 
people find easy 
to use, and which 
cause problems 
Participants should be representative 
of the intended user population(s), 
and tasks used in should provide 
good coverage of real-world use. 
Yields insights into HIT design but not 
how it fits in the broader work 
context. 
RCT Testing the HIT with 
representative users 
under controlled 
conditions to test a 
hypothesis about health 
outcomes  
Testing the 
effectiveness of 
HIT for achieving 
health outcomes 
Need a valid comparator, and 
conditions need to be as realistic as 
possible while remaining controlled. 
 
  
12 
 
Figure 1: Flow diagram guiding the choice of evaluation approaches 
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